Effect of Nasal Continuous Positive Airway Pressure vs Heated Humidified High-Flow Nasal Cannula on Feeding Intolerance in Preterm Infants With Respiratory Distress Syndrome
Authors: Francesco Cresi, Elena Maggiora, Gianluca Lista, Carlo Dani, Silvia M. Borgione, Elena Spada, Mattia Ferroglio, Enrico Bertino, Alessandra Coscia, Michela Fiora, Sara Colombo, Chiara Peila, Mattia Luciano, Fabio Meneghin, Sara Gatto, Enrica Lupo, Serena Elia, Martina Ciarcià, Fabio Mosca, Anna Orsi, Domenica Mercadante, Matilde Amatruda, Barbara Tomasini, Sara Cecchi, Pamela Liuzzo Lasagna, Stefano Martinelli, Laura Ilardi, Alice Proto, Giovanni Vento, Simonetta Costa, Francesca P Fusco, Daniele Farina, Maria F Campagnoli, Tatiana Boetti, Elena Boano, Andrea Sannia, Cinzia De Maio, Eleonora Murizasco, Francesco Raimondi, Letizia Capasso, Serena Salomè, Massimo Agosti, Laura Morlacchi, Simona Perniciaro, Nicola Laforgia, Mariella Baldassarre, Manuela Capozza, Mauro Stronati, Elisa Civardi, Francesca Garofoli, Luca Maggio, Luigi Corvaglia
Journal: JAMA Network Open (2023)

Importance Respiratory distress syndrome and feeding intolerance are common conditions that are often associated with preterm infants. Showing similar efficacy, nasal continuous positive airway pressure (NCPAP) and heated humidified high-flow nasal cannula (HHHFNC) are the most widespread noninvasive respiratory support (NRS) in neonatal intensive care units, but their effect on feeding intolerance is unknown. Objective To evaluate the effect of NCPAP vs HHHFNC on high-risk preterm infants with respiratory distress syndrome. Design, Setting, and Participants This multicenter randomized clinical trial involved infants who were born in 1 of 13 neonatal intensive care units in Italy between November 1, 2018, and June 30, 2021. Preterm infants with a gestational age of 25 to 29 weeks, who were suitable for enteral feeding and who proved to be medically stable on NRS for at least 48 hours were enrolled in the study within the first week of life and randomized to receive either NCPAP or HHHFNC. Statistical analysis was performed according to the intention-to-treat approach. Intervention NCPAP or HHHFNC. Main Outcomes and Measures The primary outcome was the time to full enteral feeding (FEF), defined as an enteral intake of 150 mL/kg per day. Secondary outcomes were the median daily increment of enteral feeding, signs of feeding intolerance, effectiveness of the assigned NRS, peripheral oxygen saturation (SpO 2 )–fraction of inspired oxygen ( FIO 2 ) ratio at changes of NRS, and growth. Results Two-hundred forty-seven infants (median [IQR] gestational age, 28 [27-29] weeks; 130 girls [52.6%]) were randomized to the NCPAP group (n = 122) or the HHHFNC group (n = 125). There were no differences in the primary and secondary nutritional outcomes between the 2 groups. The median time to reach FEF was 14 days (95% CI, 11-15 days) in the NCPAP group and 14 days (95% CI, 12-18 days) in the HHHFNC group, and similar results were observed in the subgroup of infants with less than 28 weeks’ gestation. On the first NRS change, higher SpO 2 – FIO 2 ratio (median [IQR], 4.6 [4.1-4.7] vs 3.7 [3.2-4.0]; P &amp;amp;lt; .001) and lower rate of ineffectiveness (1 [4.8%] vs 17 [73.9%]; P &amp;amp;lt; .001) were observed in the NCPAP vs HHHFNC group. Conclusions and relevance This randomized clinical trial found that NCPAP and HHHFNC had similar effects on feeding intolerance, despite different working mechanisms. Clinicians may tailor respiratory care by selecting and switching between the 2 NRS techniques on the basis of respiratory effectiveness and patient compliance, without affecting feeding intolerance. Trial Registration ClinicalTrials.gov Identifier: NCT03548324